Category: Finance
-
Sanofi Buys Nano-Antibody Biotech in $4.8B Deal
Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion.
-
NIH Funding Immune-Friendly Synthetic Vascular Grafts
A bioengineering lab is receiving a National Institutes of Health grant to advance development of more tolerable synthetic veins and arteries implanted in heart bypass patients.
-
T-Cell Therapy Company Gains $100M in Venture Funds
A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round.
-
Blood Disorder Drug Maker Acquired in $11.6B Deal
The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders.
-
Small Business Grant Advances Drug Safety Test System
An award from National Institutes of Health is advancing a technology for testing the safety of drugs with heart muscle cells derived from stem cells before the drugs are tested on humans.
-
Celgene Acquires Cancer Drug Start-Up in $7B Deal
The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion.
-
Investing In The Future Of Technology
Knowing where to put your money is hard, as the changes in this industry are incredibly rapid, and new trends are appearing all the time.
-
RNA Therapies Start-Up Raises $55.3M in Early Funds
A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round.
-
NIH Grant Funds Synthetic Peptide for Severe Asthma
A synthetic peptide, a short chain of amino acids, is being developed as a treatment for severe cases of asthma that do not respond to conventional drugs.
-
Cell Engineering Company Launches, Raises $4.7 Million
A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts.